It is called a targeted therapy because it exclusively targets the CD38 which happen to be overexpressed on the multiple myeloma cells. Daratumumab is from a class of medicines known as CD38 monoclonal antibodies. Animal experiments have connected semaglutide to thyroid C-mobile tumors, however the risk in people is unknown. https://ferdinandq379chn9.bcbloggers.com/profile